Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
21.83
+0.18 (0.83%)
Jun 9, 2026, 3:00 PM CST
SHA:600196 Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, SHA:600196 stock has a consensus rating of "Buy" and an average price target of ¥36.14. The average 1-year stock price forecast is 65.55% higher than the current stock price, while the lowest is ¥28.50 (+30.55%) and the highest is ¥44.00 (+101.56%).
Price Target: ¥36.14 (+65.55%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHA:600196 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 2 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 7 | 6 | 7 |
Financial Forecast
Revenue This Year
43.27B
from 41.66B
Increased by 3.87%
Revenue Next Year
45.33B
from 43.27B
Increased by 4.76%
EPS This Year
1.20
from 0.88
Increased by 36.36%
EPS Next Year
1.40
from 1.20
Increased by 16.67%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 43.8B | ||
| Avg | 43.3B | ||
| Low | 42.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.1% | ||
| Avg | 3.9% | ||
| Low | 1.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.20 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 36.4% | ||
| Low | - |